Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy Axonics, which was announced in January.

Medtronic (NYSE: MDT) says Dr. James Porter joined the company as CMO of Robotic Surgical Technologies and Digital ...

Medtronic is bringing on a new chief medical officer for its digital and robotics teams, who it described as one of the top ...

From new leadership and expansions, here are five key updates from spine and orthopedic devicemakers since Sept. 11.

Medtronic appoints Dr. James Porter as CMO for robotic and digital technologies, tasked with driving innovation and clinical evidence plans.

Shares of Medtronic PLC climbed toward a three-month high in early Tuesday trading, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its ...

Medtronic Plc is a medical technology company ... Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for ...

The company operates in four business segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. Medtronic sells products in many end markets in these segments. It is usually the ...

Aug 20 (Reuters) - Medtronic (MDT.N), opens new tab slightly ... posted a revenue beat across segments except for its medical surgical unit, which was affected by a slowdown in the Korean market ...

WANG GANG / Feature China / Future Publishing via Getty Images Medtronic beat first-quarter ... million at its diabetes segment. The medical surgical unit sales declined 0.4% to $2.00 billion.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...